Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 294.40%38.8M | 224.10%33.25M | -32.37%57.28M | -14.56%90.78M | 512.79%23.03M | -57.10%9.84M | -192.56%-26.79M | 67.32%84.7M | 200.23%106.25M | 138.96%3.76M |
| Net profit before non-cash adjustment | -21.14%28.92M | -3.14%26.89M | 61.26%20.51M | 59.36%100.95M | 21.61%23.81M | 95.33%36.67M | 116.49%27.76M | 4.43%12.72M | 23.63%63.35M | 17.28%19.58M |
| Total adjustment of non-cash items | 9.69%14.15M | -9.49%11.38M | 21.52%13.36M | 21.25%56.65M | 50.32%20.19M | -1.04%12.9M | 10.72%12.57M | 23.45%10.99M | 13.15%46.72M | -26.28%13.43M |
| -Depreciation and amortization | 1.72%7.7M | -3.23%7.4M | -6.27%7.26M | -8.85%30.05M | -14.92%7.09M | -8.43%7.57M | -7.05%7.64M | -4.86%7.75M | -1.68%32.97M | 1.09%8.34M |
| -Reversal of impairment losses recognized in profit and loss | 80.71%-93K | -82.01%84K | 88.57%-67K | 4.70%3.33M | 11.15%3.93M | -618.28%-482K | 319.25%467K | -148.31%-586K | 324.79%3.18M | 61.74%3.54M |
| -Assets reserve and write-off | -25.52%1.11M | -92.37%-2.02M | 6.84%-558K | 21.58%2.06M | 75.96%2.21M | 2,196.92%1.49M | -328.16%-1.05M | -197.40%-599K | 275.04%1.69M | 291.17%1.26M |
| -Share of associates | 52.49%-887K | 15.30%-1.69M | 35.39%-1.22M | -21.44%-6.93M | 25.88%-1.17M | -62.21%-1.87M | -77.30%-2M | -2.38%-1.89M | 11.58%-5.71M | -6.64%-1.58M |
| -Disposal profit | 94.59%-388K | 146.91%349K | -61.11%555K | -279.22%-3.78M | 2,739.00%2.7M | -1,961.30%-7.17M | -807.32%-744K | 202.22%1.43M | -2,338.23%-997.94K | -98.01%95.06K |
| -Net exchange gains and losses | -107.34%-210K | -576.06%-1.01M | -70.57%620K | 410.55%2.76M | 21.40%-2.42M | 493.78%2.86M | -39.83%213K | 55.04%2.11M | -313.63%-888.3K | -273.65%-3.08M |
| -Deferred income tax | -34.64%7.77M | -4.04%9.37M | 70.50%7.78M | 63.48%35.26M | 41.73%9.03M | 81.20%11.89M | 76.86%9.77M | 46.88%4.56M | 26.85%21.57M | -3.69%6.37M |
| -Other non-cash items | 38.96%-854K | 36.38%-1.1M | 43.02%-1.01M | -19.55%-6.09M | 21.32%-1.19M | 16.03%-1.4M | -60.09%-1.73M | -111.18%-1.78M | -131.97%-5.09M | -134.40%-1.51M |
| Changes in working capital | 89.25%-4.27M | 92.53%-5.02M | -61.60%23.42M | -1,648.89%-66.83M | 28.32%-20.97M | -347.58%-39.73M | -1,506.75%-67.12M | 106.48%60.99M | 93.31%-3.82M | 34.35%-29.25M |
| -Change in receivables | -1,342.45%-46.18M | 65.03%-28.2M | 4.63%45.65M | -190.22%-83.8M | -319.80%-50.49M | 109.68%3.72M | -413.39%-80.66M | -72.56%43.63M | 171.21%92.89M | 91.12%-12.03M |
| -Change in inventory | -180.52%-8.1M | 138.22%2.94M | 384.00%25.53M | -247.24%-29.22M | -322.21%-22.6M | 333.93%10.06M | -165.07%-7.7M | -153.26%-8.99M | 289.53%19.85M | 136.87%10.17M |
| -Change in payables | 220.65%50.74M | 131.89%27.69M | -375.47%-76.87M | 139.64%46.2M | 645.33%48.41M | -310.17%-42.06M | -54.35%11.94M | 118.14%27.91M | -239.15%-116.56M | -107.07%-8.88M |
| -Changes in other current assets | 93.64%-728K | -180.02%-7.44M | 1,970.31%29.1M | -219.06%-16.58M | -179.86%-12.87M | -183.02%-11.45M | 435.30%9.3M | -120.75%-1.56M | --13.92M | ---4.6M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -202.35%-514K | -106.45%-192K | -839.13%-216K | -136.85%-470.16K | -484.51%-184.16K | -347.37%-170K | -78.85%-93K | 70.13%-23K | 68.27%-198.51K | 68.97%-31.51K |
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | -8.37%-10.28M | -35.85%-6.92M | -60.17%-11.08M | -30.24%-35.5M | -19.69%-14.01M | -100.17%-9.48M | 29.80%-5.09M | -94.19%-6.92M | -113.15%-27.26M | -180.42%-11.7M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 15,203.28%28.01M | 181.75%26.14M | -40.86%45.99M | -30.44%54.81M | 210.83%8.84M | -98.99%183K | -247.75%-31.97M | 65.51%77.76M | 258.53%78.8M | 42.70%-7.98M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -83.12%-10.79M | 58.36%-7.8M | -25.46%-3.91M | -187.39%-34.51M | -129.18%-6.78M | -113.55%-5.89M | -290.49%-18.72M | -108.36%-3.12M | -120.66%-12.01M | -126.25%-2.96M |
| Net business purchase and sale | --0 | ---- | ---- | ---7.26M | ---7.26M | --0 | ---- | ---- | --0 | ---- |
| Net investment product transactions | -376.13%-23.63M | 112.04%13.82M | ---71.87M | 153.72%626.73K | 908.05%106.81M | 172.76%8.56M | ---114.74M | --0 | ---1.17M | --10.6M |
| Advance cash and loans provided to other parties | ---1K | ---- | ---- | -14.41%-166.52K | ---- | ---- | ---- | ---- | -205.78%-145.55K | ---- |
| Repayment of advance payments to other parties and cash income from loans | -98.51%49K | 467.50%147K | -5.21%182K | ---- | ---- | --3.29M | 47.37%-40K | 39.13%192K | --813 | ---- |
| Dividends received (cash flow from investment activities) | 150.03%1.6M | -40.00%1.92M | 64,100.00%1.28M | -41.67%4.48M | 133.45%4.48M | -266.56%-3.2M | 66.67%3.2M | -100.10%-2K | 33.33%7.68M | -0.05%1.92M |
| Interest received (cash flow from investment activities) | -97.83%37K | -58.65%753K | -33.97%970K | 7.29%4.97M | -101.90%-26.19K | 3.33%1.71M | 100.77%1.82M | 111.06%1.47M | 79.10%4.63M | 91.22%1.38M |
| Investing cash flow | -840.38%-33.02M | 90.46%-12.26M | -4,937.36%-73.34M | -3,057.39%-31.87M | 772.97%93.61M | 140.73%4.46M | -6,188.60%-128.48M | -215.56%-1.46M | -146.69%-1.01M | 784.99%10.72M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -60.36%-3.33M | 70.47%17.18M | -54.00%2.3M | 291.74%13M | --0 | -246.00%-2.08M | 410.99%10.08M | 270.07%5M | 69.24%-6.78M | --0 |
| Increase or decrease of lease financing | -41.06%-663K | 405.52%1.49M | -707.35%-3.08M | -33.34%-1.82M | -3.06%-476.31K | -59.32%-470K | -61.92%-489K | -25.74%-381K | -8.35%-1.36M | -50.43%-462.19K |
| Cash dividends paid | 0.01%-16.06M | --0 | -43.25%-21.28M | -46.67%-30.92M | -13.83%380 | -99.99%-16.06M | --0 | -13.85%-14.86M | -64.06%-21.08M | 53.13%441 |
| Cash dividends for minorities | -114.35%-7.35M | 75.59%-406K | -60.00%-3.92M | -20.45%-12.44M | 16.65%-4.9M | -133.27%-3.43M | -62.88%-1.66M | -25.00%-2.45M | -352.87%-10.33M | -2,939,780.00%-5.88M |
| Net other fund-raising expenses | ---- | ---- | ---- | 84.50%-1.27M | 99.74%-25K | -167.50%-8.39M | -67.32%-1.11M | 181.55%8.26M | -5,606.90%-8.16M | -237.84%-9.79M |
| Financing cash flow | 14.90%-25.89M | 168.09%18.27M | -486.68%-25.98M | 32.56%-32.18M | 74.36%-4.14M | -1,597.39%-30.43M | 230.34%6.81M | 84.40%-4.43M | -23.70%-47.71M | -518.17%-16.14M |
| Net cash flow | ||||||||||
| Beginning cash position | 43.24%167.31M | -50.07%135.05M | -4.94%188.45M | 17.62%198.24M | -57.50%90M | -42.33%116.8M | 43.77%270.47M | 17.62%198.24M | -8.09%168.54M | 18.23%211.78M |
| Current changes in cash | -19.87%-30.91M | 120.92%32.14M | -174.20%-53.33M | -130.70%-9.23M | 834.16%98.31M | -379.11%-25.78M | -1,169.15%-153.64M | 261.92%71.88M | 308.42%30.08M | -51.27%-13.39M |
| Effect of exchange rate changes | 44.61%-565K | 487.10%120K | -120.29%-71K | -49.69%-558.84K | 201.30%142.16K | -50,900.00%-1.02M | -188.57%-31K | 231.58%350K | 8.42%-373.34K | 89.08%-140.34K |
| End cash Position | 50.93%135.84M | 43.24%167.31M | -50.07%135.05M | -4.94%188.45M | -4.94%188.45M | -57.50%90M | -42.33%116.8M | 43.77%270.47M | 17.62%198.24M | 17.62%198.24M |
| Free cash flow | 390.58%16.93M | 136.18%18.34M | -43.67%42.05M | -70.89%19.42M | 111.86%1.3M | -137.84%-5.83M | -401.19%-50.69M | 64.26%74.65M | 398.61%66.73M | 28.17%-10.94M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.